These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Quantitative serum free light chain assay in the diagnostic evaluation of AL amyloidosis. Akar H; Seldin DC; Magnani B; O'Hara C; Berk JL; Schoonmaker C; Cabral H; Dember LM; Sanchorawala V; Connors LH; Falk RH; Skinner M Amyloid; 2005 Dec; 12(4):210-5. PubMed ID: 16399645 [TBL] [Abstract][Full Text] [Related]
3. Detection of kappa and lambda light chain monoclonal proteins in human serum: automated immunoassay versus immunofixation electrophoresis. Jaskowski TD; Litwin CM; Hill HR Clin Vaccine Immunol; 2006 Feb; 13(2):277-80. PubMed ID: 16467338 [TBL] [Abstract][Full Text] [Related]
4. Assessment of serum free light chain assays for plasma cell disorder screening in a Veterans Affairs population. Abadie JM; Bankson DD Ann Clin Lab Sci; 2006; 36(2):157-62. PubMed ID: 16682511 [TBL] [Abstract][Full Text] [Related]
5. A new concept for detection of Bence Jones proteinuria in patients with monoclonal gammopathy. Hofmann W; Garbrecht M; Bradwell AR; Guder WG Clin Lab; 2004; 50(3-4):181-5. PubMed ID: 15074473 [TBL] [Abstract][Full Text] [Related]
6. Assessment of the analytical performance and the sensitivity of serum free light chains immunoassay in patients with monoclonal gammopathy. Wolff F; Thiry C; Willems D Clin Biochem; 2007 Mar; 40(5-6):351-4. PubMed ID: 17239359 [TBL] [Abstract][Full Text] [Related]
7. Development of a highly-sensitive multi-plex assay using monoclonal antibodies for the simultaneous measurement of kappa and lambda immunoglobulin free light chains in serum and urine. Campbell JP; Cobbold M; Wang Y; Goodall M; Bonney SL; Chamba A; Birtwistle J; Plant T; Afzal Z; Jefferis R; Drayson MT J Immunol Methods; 2013 May; 391(1-2):1-13. PubMed ID: 23388695 [TBL] [Abstract][Full Text] [Related]
8. Strengths and weaknesses of methods for identifying monoclonal free light chains of Ig: examples from two cases with renal disease. Levinson SS Clin Chem Lab Med; 2016 Jun; 54(6):1039-43. PubMed ID: 26368046 [TBL] [Abstract][Full Text] [Related]
9. Polyclonal free light chain of Ig may interfere with interpretation of monoclonal free light chain κ/λ ratio. Levinson SS Ann Clin Lab Sci; 2010; 40(4):348-53. PubMed ID: 20947809 [TBL] [Abstract][Full Text] [Related]
10. Can serum free light chains replace urine electrophoresis in the detection of monoclonal gammopathies? Beetham R; Wassell J; Wallage MJ; Whiteway AJ; James JA Ann Clin Biochem; 2007 Nov; 44(Pt 6):516-22. PubMed ID: 17961305 [TBL] [Abstract][Full Text] [Related]
11. Quantification of serum free light chain kappa and lambda by the SPAPLUS analyser. Maisin D; Lepoutre T; Gruson D; Wallemacq P Clin Biochem; 2013 May; 46(7-8):622-6. PubMed ID: 23291296 [TBL] [Abstract][Full Text] [Related]
12. Analytical performance of the serum free light chain assay. Briand PY; Decaux O; Caillon H; Grosbois B; Le Treut A; Guenet L Clin Chem Lab Med; 2010; 48(1):73-9. PubMed ID: 19929752 [TBL] [Abstract][Full Text] [Related]
13. Clinical comparison of new monoclonal antibody-based nephelometric assays for free light chain kappa and lambda to polyclonal antibody-based assays and immunofixation electrophoresis. Hoedemakers RM; Pruijt JF; Hol S; Teunissen E; Martens H; Stam P; Melsert R; Te Velthuis H Clin Chem Lab Med; 2011 Nov; 50(3):489-95. PubMed ID: 22098433 [TBL] [Abstract][Full Text] [Related]
14. Studies of Bence Jones proteins by immunonephelometry. Levinson SS Ann Clin Lab Sci; 1992; 22(2):100-9. PubMed ID: 1562164 [TBL] [Abstract][Full Text] [Related]
15. Urine immunofixation electrophoresis remains important and is complementary to serum free light chain. Levinson SS Clin Chem Lab Med; 2011 Nov; 49(11):1801-4. PubMed ID: 21663562 [TBL] [Abstract][Full Text] [Related]
16. Novel extended reference range for serum kappa/lambda free light chain ratio in diagnosing monoclonal gammopathies in renal insufficient patients. Diamantidis MD; Ioannidou-Papagiannaki E; Ntaios G Clin Biochem; 2009 Jul; 42(10-11):1202-3. PubMed ID: 19375413 [No Abstract] [Full Text] [Related]
17. Clinical and preclinical validation of the serum free light chain assay: identification of the critical difference for optimized clinical use. Hansen CT; Münster AM; Nielsen L; Pedersen P; Abildgaard N Eur J Haematol; 2012 Dec; 89(6):458-68. PubMed ID: 22998393 [TBL] [Abstract][Full Text] [Related]
18. Serum free light chain specificity and sensitivity: a reality check. Katzmann JA Clin Chem; 2006 Sep; 52(9):1638-9. PubMed ID: 16940461 [No Abstract] [Full Text] [Related]
19. A multicentre study comparing two methods for serum free light chain analysis. Lock RJ; Saleem R; Roberts EG; Wallage MJ; Pesce TJ; Rowbottom A; Cooper SJ; McEvoy ED; Taylor JL; Basu S Ann Clin Biochem; 2013 May; 50(Pt 3):255-61. PubMed ID: 23605135 [TBL] [Abstract][Full Text] [Related]
20. Direct Detection of Monoclonal Free Light Chains in Serum by Use of Immunoenrichment-Coupled MALDI-TOF Mass Spectrometry. Sepiashvili L; Kohlhagen MC; Snyder MR; Willrich MAV; Mills JR; Dispenzieri A; Murray DL Clin Chem; 2019 Aug; 65(8):1015-1022. PubMed ID: 31171529 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]